Cover Image
市場調查報告書

嘔吐:全球臨床實驗趨勢

Emesis (Vomiting) Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 332927
出版日期 內容資訊 英文 97 Pages
訂單完成後即時交付
價格
Back to Top
嘔吐:全球臨床實驗趨勢 Emesis (Vomiting) Global Clinical Trials Review, H1, 2015
出版日期: 2015年04月30日 內容資訊: 英文 97 Pages
簡介

本報告提供嘔吐相關臨床研究的最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,受驗者採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 嘔吐
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:腸胃疾病治療藥臨床實驗上嘔吐的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:腸胃疾病治療藥臨床實驗上嘔吐的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

嘔吐治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Sky Growth Intermediate Holdings II Corporation
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • Vimta Labs Ltd
    • Duchesnay Inc.
    • Altasciences Company Inc
    • Novum Pharmaceutical Research Services, Inc.
    • Boehringer Ingelheim GmbH
    • BioDelivery Sciences International, Inc.
    • Astellas Pharma Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Seoul National University Hospital
    • Department of Health, UK
    • Tehran University of Medical Sciences
    • The Hospital for Sick Children
    • Arak University of Medical Sciences
    • Babol University of Medical Sciences
    • Duke University
    • Virginia Commonwealth University
    • Federal University of Mato Grosso do Sul
    • ?松醫科大學

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2674CTIDB

GlobalData's clinical trial report, "Emesis (Vomiting) Global Clinical Trials Review, H1, 2015" provides data on the Emesis (Vomiting) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Emesis (Vomiting). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Emesis (Vomiting). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Emesis (Vomiting)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Emesis (Vomiting) to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Emesis (Vomiting) to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Emesis (Vomiting)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Emesis (Vomiting) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Sky Growth Intermediate Holdings II Corporation
      • Clinical Trial Overview of Sky Growth Intermediate Holdings II Corporation
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Vimta Labs Ltd
      • Clinical Trial Overview of Vimta Labs Ltd
      • Duchesnay Inc.
      • Clinical Trial Overview of Duchesnay Inc.
      • Altasciences Company Inc
      • Clinical Trial Overview of Altasciences Company Inc
      • Novum Pharmaceutical Research Services, Inc.
      • Clinical Trial Overview of Novum Pharmaceutical Research Services, Inc.
      • Boehringer Ingelheim GmbH
      • Clinical Trial Overview of Boehringer Ingelheim GmbH
      • BioDelivery Sciences International, Inc.
      • Clinical Trial Overview of BioDelivery Sciences International, Inc.
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • Department of Health, UK
      • Clinical Trial Overview of Department of Health, UK
      • Tehran University of Medical Sciences
      • Clinical Trial Overview of Tehran University of Medical Sciences
      • The Hospital for Sick Children
      • Clinical Trial Overview of The Hospital for Sick Children
      • Arak University of Medical Sciences
      • Clinical Trial Overview of Arak University of Medical Sciences
      • Babol University of Medical Sciences
      • Clinical Trial Overview of Babol University of Medical Sciences
      • Duke University
      • Clinical Trial Overview of Duke University
      • Virginia Commonwealth University
      • Clinical Trial Overview of Virginia Commonwealth University
      • Federal University of Mato Grosso do Sul
      • Clinical Trial Overview of Federal University of Mato Grosso do Sul
      • Hamamatsu University School of Medicine
      • Clinical Trial Overview of Hamamatsu University School of Medicine
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Emesis (Vomiting) Therapeutics, Global, Clinical Trials by Region, 2015*
  • Emesis (Vomiting) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Emesis (Vomiting) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Emesis (Vomiting) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Emesis (Vomiting) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Emesis (Vomiting) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Emesis (Vomiting) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Emesis (Vomiting) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Emesis (Vomiting) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Emesis (Vomiting) Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Emesis (Vomiting) Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Emesis (Vomiting) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Emesis (Vomiting) Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Emesis (Vomiting) Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Emesis (Vomiting) Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Emesis (Vomiting) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sky Growth Intermediate Holdings II Corporation, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by Vimta Labs Ltd, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duchesnay Inc., 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by Altasciences Company Inc, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novum Pharmaceutical Research Services, Inc., 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by BioDelivery Sciences International, Inc., 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by Babol University of Medical Sciences, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by Virginia Commonwealth University, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Mato Grosso do Sul, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamamatsu University School of Medicine, 2015*

List of Figures

  • Emesis (Vomiting) Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Emesis (Vomiting) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Emesis (Vomiting) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Emesis (Vomiting) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Emesis (Vomiting) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Emesis (Vomiting) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Emesis (Vomiting) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Emesis (Vomiting) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Emesis (Vomiting) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Emesis (Vomiting) Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Emesis (Vomiting) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Emesis (Vomiting) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Emesis (Vomiting) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Emesis (Vomiting) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
c
Back to Top